System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Lonnie Zwaigenbaum is an expert in Pediatrics at Glenrose Rehabilitation Hospital (Canada). As of October 2026, ScienceLeadR ranks Lonnie Zwaigenbaum in the top 1% of experts worldwide for Autism Spectrum Disorder, Autistic Disorder and Child Behavior Disorders. Lonnie Zwaigenbaum has authored 434 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 1,249 (community average: 125). How the SLR is computed.

LeadR Profile

Lonnie Zwaigenbaum Glenrose Rehabilitation Hospital Canada
1 249 ScienceLeadR Reputation 1249

Unlock

Register Login
Network Map

Pediatrics

Subspecialties: Psychiatry - Neurology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026
Source: PubMed

University of Alberta

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 434

Citations

Citations: 45 059 1st author: 36 Last author: 57 Unique author: 13

Main journals

J Autism Dev Disord 61
Autism 28
Paediatr Child Health 28
Autism Res 24
J Child Psychol Psychiatry 18

Best Journals

Nature 4
JAMA 3
BMJ 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Short Report: An Examination of Children's Autism Traits and Their Association With Family Experience.
PMID 42415507 — parenting, autistic disorder, diagnosis, child		Autism Res20260
Mental health disorders and suicide risk among autistic children, adolescents and adults: a population-based study using linked administrative data.
PMID 42338461 — conduct disorder, cohort studies, autistic disorder, adolescent, schizophrenia, prevalence, anxiety disorders, sex, mental health, suicide, attempted, child, suicide, attention deficit disorder with hyperactivity		Lancet Reg Health Am20262
An e-health transition intervention for youth with brain-based disabilities: Pilot and feasibility results from a Randomized Controlled Trial.
PMID 42317484 — pilots, brain, health transition		Health Care Transit20260
Advances in supporting development in autistic children and youth.
PMID 42270130 — child		BMJ Top journal20260
Letter to the Editor: 'Key links between autistic characteristics and anxiety symptoms in autistic children and youth': a response to Lai et al. (2026).
PMID 42262068 — autism spectrum disorder, signs and symptoms, child		Child Adolesc Ment Health20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 5
Phase 4 1

By status:

Completed 3
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
AWARE Management of ADHD in Autism Spectrum Disorder
NCT05916339 — guanfacine, autism spectrum disorder, methylphenidate, adenosine monophosphate, tablets, adenosine, autistic disorder, clonidine, therapeutics, names, random allocation, amphetamine, child, attention deficit disorder with hyperactivity		Phase 4Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS